(S)-M-Methoxyamphetamine

(S)-M-Methoxyamphetamine

SCHEMBL30813013

COc1cccc(CC(C)N)c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ TAAR1 Q96RJ0 5/20 1.00
▸ SLC6A4 P31645 2/20 0.63
▸ IDO1 P14902 2/20 0.59
▸ AGXT P21549 2/20 0.59
▸ PNMT P11086 1/20 0.56
▸ SLC6A2 P23975 2/20 0.55
▸ MAOA P21397 1/20 0.55
▸ SLC6A3 Q01959 1/20 0.55
▸ SIGMAR1 Q99720 1/20 0.55
▸ CYP2A6 P11509 1/20 0.55
▸ ADORA2A P29274 1/20 0.55
▸ ADORA1 P30542 1/20 0.55
▸ HTR2A P28223 2/20 0.55
▸ HTR2C P28335 1/20 0.55
▸ HTR2B P41595 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
(S)-M-Methoxyamphetamine SCHEMBL269071 1.00 TAAR1 (1.00) TAAR1SLC6A4IDO1AGXTPNMT
(S)-M-Methoxyamphetamine SCHEMBL3293027 1.00 TAAR1 (1.00) TAAR1SLC6A4IDO1AGXTPNMT
(S)-M-Methoxyamphetamine SCHEMBL11461072 1.00 TAAR1 (1.00) TAAR1SLC6A4IDO1AGXTPNMT
(S)-M-Methoxyamphetamine SCHEMBL30559562 0.98 TAAR1 (0.96) TAAR1SLC6A4IDO1AGXTPNMT
(S)-M-Methoxyamphetamine SCHEMBL31545212 0.87 TAAR1 (0.77) TAAR1SLC6A4IDO1AGXTPNMT
SCHEMBL449889 0.86 TAAR1 (0.76) TAAR1IDO1AGXTSIGMAR1
SCHEMBL151945 0.85 TAAR1 (0.74) TAAR1IDO1AGXTSIGMAR1
SCHEMBL8747069 0.85 TAAR1 (0.74) TAAR1IDO1AGXTSIGMAR1
SCHEMBL6224557 0.85 TAAR1 (0.73) TAAR1IDO1AGXTSIGMAR1
SCHEMBL13349231 0.84 TAAR1 (0.72) TAAR1SLC6A4IDO1AGXTSIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117715632-A Compositions comprising an enzyme-cleavable prodrug and nafamostat and methods of use thereof 恩赛斯生物科学股份有限公司 2024-03-15 — — CN disclosed
Send feedback